Targeting NMDAR2A in microglia: esketamine suppresses M1 polarization in BV2 cells
Molecular Biology Reports · 2026
DOI: 10.1007/s11033-026-12874-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Hui Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, Guizhou Province, China. Hauptthemen laut MEDLINE: Microglia, Receptors, N-Methyl-D-Aspartate. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Guizhou Provincial Department of Education Youth Science and Technology Talent Growth Project, Science and Technology Fund of Guizhou Provincial Health Commission, Start-up Fund of Affiliated Hospital of Guizhou Medical University.
Abstract (Originalsprache)
OBJECTIVE: Microglial polarization toward the M1 phenotype is a key contributor to the initiation and progression of neuroinflammatory diseases, primarily through the release of pro-inflammatory cytokines that exacerbate central nervous system-associated injury. Activation of N-methyl-D-aspartic acid receptors (NMDARs) is implicated in microglial overactivation and cytotoxicity. This study aimed to investigate the role of esketamine, a non-competitive NMDAR antagonist, on microglial polarization. METHODS: BV2 microglial cells were used as an in vitro model. Inhibitors and agonists were applied to modulate the mammalian target of rapamycin (mTOR) and brain-derived neurotrophic factor (BDNF)-tyrosine kinase receptor B (TrkB) signaling pathways. Small interfering RNA, Western blotting, enzyme-linked immunosorbent assay, and immunofluorescence staining were performed to investigate the regulatory effects and molecular targets of esketamine on BV2 cells. RESULTS: Esketamine enhanced mTOR phosphorylation and activated the BDNF-TrkB signaling pathway through NMDAR inhibition. This effect attenuated lipopolysaccharide-induced M1 polarization in BV2 microglia and reduced pro-inflammatory cytokine expression. Further analysis revealed that the anti-inflammatory effects of esketamine were primarily mediated by the NMDAR2A subtype, while the NMDAR2B subtype was not involved. CONCLUSION: Esketamine suppressed proinflammatory microglial polarization by selectively modulating the NMDAR2A subtype, leading to the activation of the mTOR signaling pathway and enhancement of the BDNF-TrkB signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, Guizhou Province, China.
- College of Anesthesia, Guizhou Medical University, Guiyang, 550004, Guizhou Province, China.
- Key Laboratory of Anesthesia and Pain Research, Guizhou Medical University, Guiyang, 550004, Guizhou Province, China.
- Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, Guizhou Province, China. yimin-ren@qq.com.
- College of Anesthesia, Guizhou Medical University, Guiyang, 550004, Guizhou Province, China. yimin-ren@qq.com.
- Key Laboratory of Anesthesia and Pain Research, Guizhou Medical University, Guiyang, 550004, Guizhou Province, China. yimin-ren@qq.com.
Förderung
- Guizhou Provincial Department of Education Youth Science and Technology Talent Growth Project
- Science and Technology Fund of Guizhou Provincial Health Commission
- Start-up Fund of Affiliated Hospital of Guizhou Medical University
- Key Laboratory of Anesthesia and Pain Research, Guizhou Medical University
- Medical Research Union Fund for High-quality Health Development of Guizhou Province
- the National Natural Science Foundation of China
- National Natural Science Foundation of China
- Basic Research Program of Guizhou Province (Natural Sciences)
Zitieren
APA
Li, H., Zhang, X., Luo, Y., Hu, W., Liu, Y., Ren, Y., & Zou, X. (2026). Targeting NMDAR2A in microglia: esketamine suppresses M1 polarization in BV2 cells. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-12874-9
Vancouver
Li H, Zhang X, Luo Y, Hu W, Liu Y, Ren Y, et al. Targeting NMDAR2A in microglia: esketamine suppresses M1 polarization in BV2 cells. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-12874-9
BibTeX
@article{Li2026,
author = {Li, Hui and Zhang, Xiaoyuan and Luo, Yushan and Hu, Wen and Liu, Yang and Ren, Yimin and Zou, Xiaohua},
title = {Targeting NMDAR2A in microglia: esketamine suppresses M1 polarization in BV2 cells},
journal = {Molecular Biology Reports},
year = {2026},
doi = {10.1007/s11033-026-12874-9}
}
EUVIMED